TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
Abstract
TLR sense microbial infections, and control activation of immune responses. Dendritic cells, macrophages, and B lymphocytes express TLR and the TLR-signaling adaptor protein MyD88. The impact of TLR-activated B cells on T cell-mediated inflammation is unknown. In this study, we have used mice carrying B cell-restricted deficiencies in MyD88 or in distinct TLR to examine the impact of TLR-activated B cells on a T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis (EAE). We demonstrate that TLR-signaling in B cells suppresses inflammatory T cell responses (both Th1 and Th17), and stimulates recovery from EAE. Only certain TLR are required on B cells for resolution of EAE, and these are dispensable for disease initiation, indicating that a category of TLR agonists preferentially triggers a suppressive function in B cells and thereby limits autoimmune disease. The TLR agonists controlling the regulatory function of B cells are provided by components of Mycobacterium tuberculosis present in the adjuvant. Thus, MyD88 signaling in B cells antagonizes MyD88 signaling in other cells, which drives differentiation of Th17 cells and is required for induction of EAE. Altogether, our data indicate that B cells link recognition of microbial products via TLR to suppression of a T cell-mediated autoimmune disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bregs are B cells with regulatory and immunosuppressive functions that maintain immunological homeostasis by producing IL-10, IL-35, and TGFβ, thereby suppressing immunopathology.
“Bregs is a generic term used to define B cells endowed with regulatory and immunosuppressive functions. They play a crucial role in maintain ing immunological homeostasis by producing anti-inflammatory cyto kines such as interleukin-10 (IL-10), IL-35, and transforming growth factor-beta (TGFβ ), thereby suppressing immunopathology.”
From Is there a role for B cells in Alzheimer's disease? (2026) · cites this paper as [58]
Breg differentiation is influenced by signals such as CD40 ligation, TLR stimulation, and cytokine exposure.
“Their differentiation is influenced by signals such as CD40 ligation, TLR stimulation, and cytokine exposure [58,63,64].”
From Is there a role for B cells in Alzheimer's disease? (2026) · cites this paper as [58]
Bregs inhibit the expansion of pathogenic T cells and other pro-inflammatory immune cells, thereby preventing excessive immune activation.
“Bregs inhibit the expansion of pathogenic T cells and other pro-inflammatory immune cells, thereby preventing excessive immune activation [55 -58].”
From Is there a role for B cells in Alzheimer's disease? (2026) · cites this paper as [58]
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1× · see citing works
“TLR have conserved key functions in vertebrates’ innate immune system (13).”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1× · see citing works
“Mammals possess at least 12 TLR that provide a powerful system to detect a broad range of pathogens including bacteria (2), mycobacteria (3), viruses (4), fungi (5), and helminths (6).”
BackgroundBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialA human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137 · cited 3× · see citing works
“Following TLR stimulation, they up-regulate costimulatory molecules essential for T cell activation (1), and secrete cytokines releasing primed T cells from the suppressive effect of regulatory T cells (22).”
BackgroundA distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 15× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialApproaching the asymptote? Evolution and revolution in immunology.Preprint
Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396 · cited 1× · see citing works
“Engagement of TLR can provide the accessory signals needed for activation of effective adaptive immune responses (1, 19, 20).”
BackgroundThe effect of infections on susceptibility to autoimmune and allergic diseases.
Bach, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,714 · cited 1× · see citing works
“Our data provide support for the “hygiene hypothesis”, which relates the sharp increase in incidence of autoimmune disorders (such as MS, type 1 diabetes, or inflammatory bowel disease) in western countries during the last 50 years to the concomitant reduction in incidence of certain infectious diseases (80).”
ResultCpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. Μ. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,570 · cited 1× · see citing works
“stimulate DC and macrophages, but fail to stimulate B cells, while type B(K) CpG oligonucleotides efficiently activate B cells (64).”
BackgroundToll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,327 · cited 3× · see citing works
“Following TLR stimulation, they up-regulate costimulatory molecules essential for T cell activation (1), and secrete cytokines releasing primed T cells from the suppressive effect of regulatory T cells (22).”
BackgroundKadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964 · cited 1× · see citing works
“Similarly, distinct DC subsets express different repertoires of TLR (66, 67).”
BackgroundIL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,841 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialA Theory of Self-Nonself Discrimination
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,755 · cited 1× · see citing works
“Engagement of TLR can provide the accessory signals needed for activation of effective adaptive immune responses (1, 19, 20).”
BackgroundB cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647 · cited 21× · see citing works
“The cells were cultured for a further 24 h before developing the cytokine ELISA with an anti-cytokine detection Ab as previously described (36).”
BackgroundMethodInfluentialSelf-citationMcGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialReceptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1× · see citing works
“Furthermore, TLR-activated macrophages secrete inflammatory cytokines driving formation of granuloma (15), which limits dissemination of the microbe, and also produce effector substances directly associated with microbe killing (16).”
BackgroundTakeuchi, O., Hoshino, K., & Akira, S. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.10.5392 · Cited by 1,156 · cited 1× · see citing works
“Mice lacking the TLR-signaling adaptor protein MyD88 show impaired survival upon infections with Staphylococcus aureus (8), Salmonella typhimurium (9), Toxoplasma gondii (10), or Mycobacterium tuberculosis (11), as a result of defects in both innate and adaptive immune defense mechanisms.”
BackgroundVisualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.
Kearney, E. R., Pape, K., Loh, D., & Jenkins, M. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 1,126 · cited 1× · see citing works
“For instance, TLR agonists can be used as adjuvant to induce strong activation of Ag-reactive T cells, while delivery of the same Ag in saline induces tolerance (21).”
BackgroundChristensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090 · cited 1× · see citing works
“Deletion of tlr-9 worsens SLE in lupus-prone mice (33, 34), and polymorphisms in tlr-9 gene leading to lower TLR-9 expression can increase predisposition to SLE in human (35).”
BackgroundRegulation of Phagosome Maturation by Signals from Toll-Like Receptors
Blander, J. M., & Medzhitov, R. (2004) · Science · doi:10.1126/science.1096158 · Cited by 991 · cited 1× · see citing works
“TLR stimulation increases the phagocytic activity of macrophages and promotes phagosome maturation, allowing efficient capture and destruction of microbes (14).”
BackgroundMizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialPrevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 858 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialHuman Toll-Like Receptors Mediate Cellular Activation by <i>Mycobacterium tuberculosis</i>
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804 · cited 1× · see citing works
“Mammals possess at least 12 TLR that provide a powerful system to detect a broad range of pathogens including bacteria (2), mycobacteria (3), viruses (4), fungi (5), and helminths (6).”
BackgroundHow can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature reviews. Immunology · doi:10.1038/35095558 · Cited by 727 · see citing works
Ito, T., Yang, M., Wang, Y.-H., Lande, R., Gregorio, J. D., Perng, O. A., Qin, X.-F. F., Liu, Y.-J., & Gilliet, M. (2007) · Journal of Experimental Medicine · doi:10.1084/jem.20061660 · Cited by 686 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialDuddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H., & Bar-Or, A. (2007) · Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 662 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialMcGeachy, M., Stephens, L. A., & Anderton, S. (2005) · Journal of Immunology · doi:10.4049/jimmunol.175.5.3025 · Cited by 602 · cited 1× · see citing works
“B cells may also suppress pathogenic T cells by interacting with regulatory T cells (60), which are also necessary for disease resolution (61).”
BackgroundSelf-citationBafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601 · cited 1× · see citing works
“In agreement with that notion, although Mycobacterium tuberculosis can stimulate DC and macrophages to produce IL-12p40 via TLR-9 in vitro (65), we found that in B cells it induces IL-10 via TLR-2 and 4 but not TLR-9.”
BackgroundNovel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis1
Evans, J., Chavez-Rueda, K., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D., Ehrenstein, M., & Mauri, C. (2007) · Journal of Immunology · doi:10.4049/jimmunol.178.12.7868 · Cited by 591 · see citing works
Scanga, C., Aliberti, J., Jankovic, D., Tilloy, F., Bennouna, S., Denkers, E., Medzhitov, R., & Sher, A. (2002) · Journal of Immunology · doi:10.4049/jimmunol.168.12.5997 · Cited by 547 · cited 1× · see citing works
“Mice lacking the TLR-signaling adaptor protein MyD88 show impaired survival upon infections with Staphylococcus aureus (8), Salmonella typhimurium (9), Toxoplasma gondii (10), or Mycobacterium tuberculosis (11), as a result of defects in both innate and adaptive immune defense mechanisms.”
BackgroundAn Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B., Dwyer, B. K., & Shevach, E. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 534 · cited 1× · see citing works
“Such modulation of DC function could contribute to regulation of EAE because alteration of the IL-10/IL-12 cytokine balance has been shown to have important effects in this disease (56, 57).”
BackgroundB cells inhibit induction of T cell-dependent tumor immunity
Qin, Z.-H., Richter, G., Schüler, T., Ibe, S., Cao, X.-T., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 440 · cited 1× · see citing works
“Furthermore, B cells can limit antitumor immunity (70).”
BackgroundConrad, D. (2005) · doi:10.3410/f.1021393.284813 · Cited by 439 · cited 1×
“As a consequence of their capacity to stimulate both innate and adaptive immunity, TLR agonists can be used to break immunological tolerance and induce autoimmune diseases such as arthritis (23), experimental autoimmune encephalomyelitis (EAE) (24), and diabetes (25).”
BackgroundTian, J.-D., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A., & Kaufman, D. (2001) · Journal of Immunology · doi:10.4049/jimmunol.167.2.1081 · Cited by 421 · cited 1× · see citing works
“They also prevent autoimmune diabetes with a mechanism that possibly involves TGF- and FasL (59).”
BackgroundDistinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1
Duddy, M., Alter, A., & Bar-Or, A. (2004) · Journal of Immunology · doi:10.4049/jimmunol.172.6.3422 · Cited by 393 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialImmunostimulatory DNA ameliorates experimental and spontaneous murine colitis
Rachmilewitz, D., Karmeli, F., Takabayashi, K., Hayashi, T., Leider–Trejo, L., Lee, J., Leoni, L. M., & Raz, E. (2002) · Gastroenterology · doi:10.1053/gast.2002.32994 · Cited by 380 · see citing works
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Prinz, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26078 · Cited by 378 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialFatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.
Fremond, C. M., Yeremeev, V., Nicolle, D., Jacobs, M., Quesniaux, V., & Ryffel, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421027 · Cited by 357 · cited 1×
“Mice lacking the TLR-signaling adaptor protein MyD88 show impaired survival upon infections with Staphylococcus aureus (8), Salmonella typhimurium (9), Toxoplasma gondii (10), or Mycobacterium tuberculosis (11), as a result of defects in both innate and adaptive immune defense mechanisms.”
BackgroundApoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells
Gray, M., Miles, K., Salter, D. M., Gray, D., & Savill, J. (2007) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0700326104 · Cited by 340 · cited 1× · see citing works
“It is notable that other signals can also facilitate IL-10 production by B cells, such as apoptotic cells and some inflammatory mediators (62, 63).”
BackgroundHelminth Infection Protects Mice from Anaphylaxis via IL-10-Producing B Cells1
Mangan, N. E., Fallon, R., Smith, P., van Rooijen, N., McKenzie, A., & Fallon, P. (2004) · Journal of Immunology · doi:10.4049/jimmunol.173.10.6346 · Cited by 321 · cited 1× · see citing works
“For instance, the tropical helminth Schistosoma mansoni induces IL-10 production by B cells (78), and thereby protects mice from anaphylaxis (79).”
BackgroundMann, M. K., Maresz, K., Shriver, L. P., Tan, Y., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3447 · Cited by 316 · cited 1× · see citing works
“B cells may also suppress pathogenic T cells by interacting with regulatory T cells (60), which are also necessary for disease resolution (61).”
BackgroundSeki, E., Tsutsui, H., Tsuji, N., Hayashi, N., Adachi, K., Nakano, H., Futatsugi-Yumikura, S., Takeuchi, O., Hoshino, K., Akira, S., et al. (2002) · Journal of Immunology · doi:10.4049/jimmunol.169.7.3863 · Cited by 307 · cited 1× · see citing works
“Innate immune responses are severely impaired in mice lacking either TLR or MyD88, often leading to a fatal growth of infecting microbes (17, 18).”
BackgroundB Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo
Moulin, V., Andris, F., Thielemans, K., Maliszewski, C., Urbain, J., & Moser, M. (2000) · Journal of Experimental Medicine · doi:10.1084/jem.192.4.475 · Cited by 305 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialKuchroo, V. K., Martin, C., Greer, J. M., Ju, S.-T., Sobel, R., & Dorf, M. (1993) · Journal of Immunology · doi:10.4049/jimmunol.151.8.4371 · Cited by 300 · cited 15× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialVelupillai, P., & Harn, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.18 · Cited by 299 · cited 1× · see citing works
“For instance, the tropical helminth Schistosoma mansoni induces IL-10 production by B cells (78), and thereby protects mice from anaphylaxis (79).”
BackgroundIntra-articularly localized bacterial DNA containing CpG motifs induces arthritis
Deng, G., Nilsson, I.-M., Verdrengh, M., Collins, L. V., & Tarkowski, A. (1999) · Nature Medicine · doi:10.1038/9554 · Cited by 295 · cited 1× · see citing works
“As a consequence of their capacity to stimulate both innate and adaptive immunity, TLR agonists can be used to break immunological tolerance and induce autoimmune diseases such as arthritis (23), experimental autoimmune encephalomyelitis (EAE) (24), and diabetes (25).”
BackgroundMellor, A. L., Baban, B., Chandler, P., Manlapat, A., Kahler, D. J., & Munn, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5601 · Cited by 285 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialEdelson, B., & Unanue, E. (2002) · Journal of Immunology · doi:10.4049/jimmunol.169.7.3869 · Cited by 274 · cited 1× · see citing works
“Innate immune responses are severely impaired in mice lacking either TLR or MyD88, often leading to a fatal growth of infecting microbes (17, 18).”
BackgroundThe risk of relapses in multiple sclerosis during systemic infections
Correale, J. D., Fiol, M. P., & Gilmore, W. (2006) · Neurology · doi:10.1212/01.wnl.0000233834.09743.3b · Cited by 273 · cited 1× · see citing works
“Although it is known that infections can increase risk of exacerbation in relapsing-remitting MS (71), the mechanisms determining remissions are largely unknown.”
BackgroundIsatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection
Horsmans, Y., Berg, T., Desager, J., Mueller, T., Schott, E., Fletcher, S., Steffy, K. R., Bauman, L., Kerr, B., & Averett, D. (2005) · Hepatology · doi:10.1002/hep.20839 · Cited by 249 · see citing works
Toll-Like Receptors Are Temporally Involved in Host Defense
Weiss, D. S., Raupach, B., Takeda, K., Akira, S., & Zychlinsky, A. (2004) · Journal of Immunology · doi:10.4049/jimmunol.172.7.4463 · Cited by 247 · cited 1× · see citing works
“Mice lacking the TLR-signaling adaptor protein MyD88 show impaired survival upon infections with Staphylococcus aureus (8), Salmonella typhimurium (9), Toxoplasma gondii (10), or Mycobacterium tuberculosis (11), as a result of defects in both innate and adaptive immune defense mechanisms.”
BackgroundParekh, V., Prasad, D. V., Banerjee, P., Joshi, B., Kumar, A., & Mishra, G. C. (2003) · Journal of Immunology · doi:10.4049/jimmunol.170.12.5897 · Cited by 246 · cited 1× · see citing works
“For instance, TLR-activated B cells can directly anergize CD8 T cells via a cell-contact dependent mechanism involving TGF- 1 (58).”
BackgroundToll-like receptor 9 signaling protects against murine lupus.
Wu, X.-B., & Peng, S. L. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21553 · Cited by 246 · cited 1× · see citing works
“Deletion of tlr-9 worsens SLE in lupus-prone mice (33, 34), and polymorphisms in tlr-9 gene leading to lower TLR-9 expression can increase predisposition to SLE in human (35).”
BackgroundRecognition of fungal pathogens by Toll-like receptors
Netea, M., Graaf, C., Meer, J. T. M., & Kullberg, B. (2004) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-004-1192-7 · Cited by 239 · cited 1× · see citing works
“Mammals possess at least 12 TLR that provide a powerful system to detect a broad range of pathogens including bacteria (2), mycobacteria (3), viruses (4), fungi (5), and helminths (6).”
BackgroundViral recognition by Toll-like receptors
Barton, G. M. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.01.003 · Cited by 209 · cited 1× · see citing works
“Mammals possess at least 12 TLR that provide a powerful system to detect a broad range of pathogens including bacteria (2), mycobacteria (3), viruses (4), fungi (5), and helminths (6).”
BackgroundHow important are Toll‐like receptors for antimicrobial responses?
Carpenter, S., & O'Neill, L. A. J. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00965.x · Cited by 182 · cited 1× · see citing works
“TLR play crucial roles in host defense mechanisms (7).”
BackgroundQuintana, F., Rotem, A., Carmi, P., & Cohen, I. (2000) · Journal of Immunology · doi:10.4049/jimmunol.165.11.6148 · Cited by 170 · see citing works
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
Wingender, G., Garbi, N., Schumak, B., Jüngerkes, F., Endl, E., von Bubnoff, D., Steitz, J., Striegler, J., Moldenhauer, G., Tüting, T., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200535602 · Cited by 169 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialTao, K., Fujii, M., Tsukumo, S., Maekawa, Y., Kishihara, K., Kimoto, Y., Horiuchi, T., Hisaeda, H., Akira, S., Kagami, S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065961 · Cited by 168 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialSegal, B. M., Chang, J. T., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5683 · Cited by 153 · cited 1× · see citing works
“As a consequence of their capacity to stimulate both innate and adaptive immunity, TLR agonists can be used to break immunological tolerance and induce autoimmune diseases such as arthritis (23), experimental autoimmune encephalomyelitis (EAE) (24), and diabetes (25).”
BackgroundAppay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Líénard, D., Guillaume, P., Krieg, A. Μ., Cerottini, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 150 · see citing works
IL-6 Increases Primed Cell Expansion and Survival
Rochman, I., Paul, W., & Ben-Sasson, S. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.8.4761 · Cited by 138 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialSkok, J., Poudrier, J., & Gray, D. (1999) · Journal of Immunology · doi:10.4049/jimmunol.163.8.4284 · Cited by 125 · see citing works
Fillatreau, S., & Gray, D. (2003) · Journal of Experimental Medicine · doi:10.1084/jem.20021750 · Cited by 124 · cited 16× · see citing works
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialSelf-citationProtection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga, A., Nakashima, H., Akahoshi, M., Masutani, K., Miyake, K., Igawa, T., Sugiyama, N., Niiro, H., & Harada, M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22571 · Cited by 118 · cited 1×
“The contribution of TLR signaling to autoimmune diseases is also indicated by the requirement for MyD88 in spontaneous development of systemic lupus erythematosus (SLE) in lupus-prone mice (26, 27).”
BackgroundMastroeni, P., Skepper, J., & Hormaeche, C. (1995) · Infection and Immunity · doi:10.1128/iai.63.9.3674-3682.1995 · Cited by 118 · cited 1× · see citing works
“Furthermore, TLR-activated macrophages secrete inflammatory cytokines driving formation of granuloma (15), which limits dissemination of the microbe, and also produce effector substances directly associated with microbe killing (16).”
BackgroundMontgomery, E. (2000) · Neurology · doi:10.1212/wnl.55.1.154 · Cited by 112 · cited 1×
“Furthermore, a Mycobacterium bovis strain bacillus Calmette-Guérin vaccine has been used to treat MS patients, and resulted in a significant reduction in lesions measured by gadolinium-enhanced magnetic resonance imaging (74).”
MethodModulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
Gilkeson, G. S., Ruiz, P., Pippen, A. M., Alexander, A. L., Lefkowith, J. B., & Pisetsky, D. S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1389 · Cited by 109 · see citing works
Jenkins, S., Hewitson, J. P., Ferret-Bernard, S., & Mountford, A. (2005) · International Immunology · doi:10.1093/intimm/dxh319 · Cited by 91 · cited 1× · see citing works
“Mammals possess at least 12 TLR that provide a powerful system to detect a broad range of pathogens including bacteria (2), mycobacteria (3), viruses (4), fungi (5), and helminths (6).”
BackgroundInflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk
Wu, H.-J. J., Sawaya, H., Binstadt, B. A., Brickelmaier, M., Blasius, A. L., Gorelik, L., Mahmood, U., Weissleder, R., Carulli, J. P., Benoist, C. O., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070285 · Cited by 90 · cited 1× · see citing works
“CD8 DC can protect mice from arthritis after CpG administration (29).”
BackgroundHigh IL-13 production by human neonatal T cells: neonate immune system regulator?
Ribeiro-do-Couto, L. M., Boeije, L. C. M., Kroon, J., Hooibrink, B., Breur-Vriesendorp, B. S., Aarden, L. A., & Boog, C. J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11 · Cited by 80 · see citing works
A Role for Inflammatory Mediators in the Induction of Immunoregulatory B Cells1
Matsumura, Y., Byrne, S., Nghiem, D., Miyahara, Y., & Ullrich, S. (2006) · Journal of Immunology · doi:10.4049/jimmunol.177.7.4810 · Cited by 79 · cited 1× · see citing works
“It is notable that other signals can also facilitate IL-10 production by B cells, such as apoptotic cells and some inflammatory mediators (62, 63).”
BackgroundTuohy, V. K., Yu, M., Yin, L., Mathisen, P. M., Johnson, J. M., & Kawczak, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00384-2 · Cited by 74 · cited 1× · see citing works
“Such modulation of DC function could contribute to regulation of EAE because alteration of the IL-10/IL-12 cytokine balance has been shown to have important effects in this disease (56, 57).”
BackgroundMyD88‐dependent autoimmune disease in Lyn‐deficient mice
Silver, K. L., Crockford, T., Bouriez‐Jones, T., Milling, S., Lambe, T., & Cornall, R. (2007) · European Journal of Immunology · doi:10.1002/eji.200737293 · Cited by 71 · cited 1× · see citing works
“The contribution of TLR signaling to autoimmune diseases is also indicated by the requirement for MyD88 in spontaneous development of systemic lupus erythematosus (SLE) in lupus-prone mice (26, 27).”
BackgroundSewell, D. L., Reinke, E., Co, D. O., Hogan, L. H., Fritz, R., Sandor, M., & Fabry, Z. (2003) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.10.4.564-572.2003 · Cited by 66 · cited 3×
“As further support of that notion, EAE can be prevented by prior injection of killed Tubercle bacillus (75, 76) or infection with bacillus Calmette-Guérin (77).”
BackgroundLehmann, D., & ben-Nun, A. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90185-s · Cited by 63 · cited 1×
“As further support of that notion, EAE can be prevented by prior injection of killed Tubercle bacillus (75, 76) or infection with bacillus Calmette-Guérin (77).”
BackgroundAndersen, E., Isager, H., & Hyllested, K. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb00756.x · Cited by 52 · cited 1× · see citing works
“An inverse correlation between previous exposure to Mycobacterium tuberculosis and MS incidence has been observed, suggesting that mycobacteria infections can protect from MS (73).”
BackgroundPrevention of Allergic Encephalomyelitis by Prior Injection of Adjuvants
Kies, M., & Alvord, E. (1958) · Nature · doi:10.1038/1821106a0 · Cited by 52 · cited 1×
“As further support of that notion, EAE can be prevented by prior injection of killed Tubercle bacillus (75, 76) or infection with bacillus Calmette-Guérin (77).”
BackgroundBuenafe, A., & Bourdette, D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.09.004 · Cited by 48 · see citing works
Flagged first, then by citations
2 of the 81 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,907 · see citing works
Immune regulatory function of B cells.
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,278 · see citing works
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251 · see citing works
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048 · see citing works
Self-citationB cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B.-L., O'Connor, R., Anderton, S., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 650 · see citing works
“However, the production of IL-10 in mice (Lampropoulou et al., 2008; Barr et al., 2010; Neves et al., 2010) and humans (Bouaziz et al., 2010) is strongly augmented by TLR signals and, indeed, these innate signals are required in vivo for the full expression of regulatory activity (Lampropoulou et…”
BackgroundMethodResultInfluentialSelf-citationRosser, E. C., Piper, C. J. M., Matei, D. E., Blair, P. A., Rendeiro, A. F., Orford, M., Alber, D. G., Krausgruber, T., Catalan, D., Klein, N., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.003 · Cited by 579 · see citing works
“Published by Elsevier Inc. 1 er the CC BY license (http://creativecommons.org/licenses/by/4.0/). levels of inflammatory cytokines, for example IFNa and/or IL-1b and IL-6, induce IL-10-producing Breg differentiation (Lampropoulou et al., 2008; Menon et al., 2016; Rosser et al., 2014).”
BackgroundInfluentialInterleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation.
Matsumoto, M., Baba, A., Yokota, T., Nishikawa, H., Ohkawa, Y., Kayama, H., Kallies, A., Nutt, S., Sakaguchi, S., Takeda, K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.016 · Cited by 543 · see citing works
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar-Or, A., Fawaz, L. M., Fan, B.-L., Darlington, P., Rieger, A., Ghorayeb, C., Calabresi, P., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521 · see citing works
“In recent years, the ‘2-signal’ model of normal human B-cell activation (involving BCR and CD40 engagement) has been extended to include ‘3rd signals’ that can modulate B-cell responses.(18,21,25,27,32) In relation to B-cell effector cytokine production, we previously reported that upon standard 2-signal activation, B…”
BackgroundAntibody-independent functions of B cells: a focus on cytokines
Shen, P., & Fillatreau, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3857 · Cited by 508 · see citing works
Self-citationYanaba, K., Bouaziz, J.-D., Matsushita, T., Tsubata, T., & Tedder, T. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900270 · Cited by 503 · see citing works
“SJL mice are susceptible to EAE after myelin proteolipid protein immunization (38).”
BackgroundInfluentialDiLillo, D. J., Matsushita, T., & Tedder, T. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05137.x · Cited by 430 · see citing works
Matsushita, T., Horikawa, M., Iwata, Y., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001307 · Cited by 394 · see citing works
“(44) have also shown that tissue culture supernatant fluid from LPS-stimulated spleen”
IL-10: A Multifunctional Cytokine in Viral Infections
Rojas, J. M., Avia, M., Martı́n, V., & Sevilla, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/6104054 · Cited by 414 · see citing works
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar‐Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 397 · see citing works
Immunosuppressive Mechanisms of Regulatory B Cells
Catalán, D., Mansilla, M. A., Ferrier, A., Soto, L., Oļeiņika, K., Aguillón, J. C., & Aravena, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611795 · Cited by 407 · see citing works
“This evidence, together with data showing that IL-10 B cells or plasmablasts inhibit Th1 and Th17-inducing DCs or induce tolerogenic DCs, in addition to direct inhibition of Th1 and Th17 cells, contribute to clarify the suppressive role of B10 in EAE and other inflammatory conditions (55, 92, 306, 307).”
BackgroundResultIntegration of B cell responses through Toll-like receptors and antigen receptors
Rawlings, D. J., Schwartz, M. A., Jackson, S. W., & Meyer‐Bahlburg, A. (2012) · Nature reviews. Immunology · doi:10.1038/nri3190 · Cited by 337 · see citing works
Role of B cells as antigen presenting cells
Rastogi, I., Jeon, D., Moseman, J. E., Muralidhar, A., Potluri, H. K., & McNeel, D. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954936 · Cited by 352 · see citing works
“Several B cell subsets, such as immature B cells, plasmablasts and mature B cells, have been shown to differentiate into IL-10-producing Bregs, upon stimulation with toll-like receptors (TLRs) and/or CD40 activation (93, 94).”
BackgroundIL-10 producing regulatory B cells in the pathogenesis of chronic HBV infection
Das, A., Ellis, G., Pallant, C., Lopes, A., Khanna, P., Peppa, D., Chen, A., Blair, P., Dusheiko, G., Gill, U., et al. (2012) · Journal of Immunology · doi:10.4049/jimmunol.1103139 · Cited by 333 · see citing works
“PBMCs were stimulated with CpG, a TLR-9 agonist, relevant in the context of the DNA virus HBV, which was shown to potently induce B cell IL-10 release (14, 24, 25).”
MethodNot always the bad guys: B cells as regulators of autoimmune pathology
Fillatreau, S., Gray, D., & Anderton, S. (2008) · Nature reviews. Immunology · doi:10.1038/nri2315 · Cited by 323 · see citing works
Self-citationToll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders
Fukata, M., Vamadevan, A. S., & Abreu, M. T. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.06.005 · Cited by 317 · see citing works
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Palomares, Ó., Akdis, M., Martín‐Fontecha, M., & Akdiş, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 336 · see citing works
BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
Covián, C., Fernández‐Fierro, A., Retamal-Díaz, A. R., Díaz, F. E., Vasquez, A. E., Lay, M. K., Riedel, C. A., González, P. A., Bueno, S. M., & Kalergis, A. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02806 · Cited by 329 · see citing works
“Also, TLR-signaling stimulated by mycobacterial components induces IL-10 secretion by B cells and consequent suppression of Th1 and Th17 activities, contributing to the suppression of autoimmune reactions (90).”
BackgroundNeves, P., Lampropoulou, V., Calderón‐Gómez, E., Roch, T., Stervbo, U., Shen, P., Kühl, A. A., Loddenkemper, C., Haury, M., Nedospasov, S. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.016 · Cited by 307 · see citing works
“Alternatively, the recently identified role of MyD88 in the suppressive functions of B cells in EAE (Lampropoulou et al., 2008) suggests that ablation ofMyd88 specifically in B cells could unleash cell-mediated immune responses and improve protection against pathogens.”
InfluentialSelf-citationKessel, A., Haj, T., Peri, R., Snir, A., Melamed, D., Sabo, E., & Toubi, E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.018 · Cited by 291 · see citing works
“B cell expression of B7 (CD86) co-stimulatory molecule was proven to be necessary for B-cell mediated suppression of EAE [33].”
InfluentialBrambilla, R., Persaud, T., Hu, X.-C., Karmally, S., Shestopalov, V., Dvoriantchikova, G., Ivanov, D., Nathanson, L., Barnum, S., & Bethea, J. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0802954 · Cited by 285 · see citing works
“Specifically, IL-10-producing B cells stimulate resolution of EAE (37), and this appears to be linked to TLR activation (38).”
BackgroundToll-like receptor signalling in B cells during systemic lupus erythematosus
Fillatreau, S., Manfroi, B., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00544-4 · Cited by 280
Self-citationRay, A., Basu, S., Williams, C. B., Salzman, N., & Dittel, B. (2012) · Journal of Immunology · doi:10.4049/jimmunol.1103354 · Cited by 278 · see citing works
“In regard to TLR ligands, the TLR-signaling adaptor protein MyD88 was found to be essential for induction of EAE when globally knocked out, but not when deficient in B cells (52).”
BackgroundB cells as therapeutic targets in SLE
Sanz, I., & Lee, F. E. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.68 · Cited by 275 · see citing works
Matsumoto, M., Fujii, Y., Baba, A., Hikida, M., Kurosaki, T., & Baba, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.016 · Cited by 262 · see citing works
IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro
Bouaziz, J., Calbo, S., Maho-Vaillant, M., Saussine, A., Bagot, M., Bensussan, A., & Musette, P. (2010) · European Journal of Immunology · doi:10.1002/eji.201040673 · Cited by 261 · see citing works
Toll‐like receptors – sentries in the B‐cell response
Bekeredjian-Ding, I., & Jego, G. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03173.x · Cited by 249 · see citing works
Role of regulatory B cells in immune tolerance to allergens and beyond.
van de Veen, W., Stanić, B., Wirz, O., Jansen, K., Głobińska, A., & Akdiş, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.006 · Cited by 239 · see citing works
The Regulatory Role of IL-10 in Neurodegenerative Diseases
Porro, C., Cianciulli, A., & Panaro, M. (2020) · Biomolecules · doi:10.3390/biom10071017 · Cited by 235 · see citing works
“Consistent to this finding, previous studies reported that CD40 stimulation triggered continuous IL-10 production by human B cells in response to TLR stimulation correlating with B cell-mediated recovery from EAE by IL-10 production [48,49], promising a novel therapeutic approach for MS.”
ResultRegulatory B cells in autoimmune diseases
Yang, M., Rui, K., Wang, S.-J., & Lu, L.-W. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.60 · Cited by 213 · see citing works
Azam, S., Jakaria, M., Kim, I.-S., Kim, J., Haque, M. E., & Choi, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01000 · Cited by 207 · see citing works
The Conserved Scavenger Receptor Cysteine-Rich Superfamily in Therapy and Diagnosis
Martínez, V. G., Moestrup, S. K., Holmskov, U., Mollenhauer, J., & Lozano, F. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004523 · Cited by 187 · see citing works
“…in the presence of microbial ligands of these PRRs has important consequences for the expansion and function of different T and B cell types, with effector as well as regulatory function (Netea et al., 2004; Caron et al., 2005; Liu et al., 2006; Lampropoulou et al., 2008; Yanaba et al., 2009).”
BackgroundResultModeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 176 · see citing works
Harada, K., Shimoda, S., Sato, Y., Isse, K., Ikeda, H., & Nakanuma, Y. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03947.x · Cited by 183 · see citing works
Regulatory B cells in autoimmunity: developments and controversies
Mauri, C., & Blair, P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.140 · Cited by 181 · see citing works
Michaud, D., Steward, C. R., Mirlekar, B., & Pylayeva-Gupta, Y. (2020) · Immunological Reviews · doi:10.1111/imr.12939 · Cited by 179 · see citing works
Piper, C. J. M., Rosser, E., Oļeiņika, K., Nistala, K., Krausgruber, T., Rendeiro, A. F., Banos, A., Drozdov, I., Villa, M., Thomson, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.018 · Cited by 168 · see citing works
“B cell receptor (BCR) engagement, Toll-like receptor (TLR) agonists lipopolysaccharide (LPS; TLR2 and TLR4) (Lampropoulou et al., 2008; Tian et al., 2001), CpG oligo-deoxynucleotides (TLR9), and inflammatory cytokines such as IL-1b and IL-6 or IFN-a are all potent inducers of B cell-derived IL-10, suggesting an import…”
BackgroundRonet, C., Torre, Y. H.-L., Revaz-Breton, M., Mastelic, B., Tacchini-Cottier, F., Louis, J., & Launois, P. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0901114 · Cited by 166 · see citing works
“Furthermore, in the EAE model, recovery was associated with the suppression of IL-12 production by DCs by IL-10 secreted by B cells (8, 45).”
BackgroundBao, Y., & Cao, X.-T. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.04.001 · Cited by 161 · see citing works
Human T cells induce their own regulation through activation of B cells.
Lemoine, S., Morva, A., Youinou, P., & Jamin, C. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.01.005 · Cited by 159
Toll-like receptors regulate B cell cytokine production in patients with diabetes
Jagannathan, M., McDonnell, M., Liang, Y., Hasturk, H., Hetzel, J., Rubin, D., Kantarci, A., Van Dyke, T. E., Ganley-Leal, L. M., & Nikolajczyk, B. S. (2010) · Diabetologia · doi:10.1007/s00125-010-1730-z · Cited by 156 · see citing works
“TLR engagement can activate B cell IL-10 production, which is critical for inflammatory disease resolution [26].”
BackgroundTolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.
Chesneau, M., Michel, L., Dugast, E., Chenouard, A., Baron, D., Pallier, A., Durand, J., Braza, F., Guerif, P., Laplaud, D., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040404 · Cited by 156 · see citing works
Evaluating the role of Toll-like receptors in diseases of the central nervous system.
Carty, M., & Bowie, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.003 · Cited by 154 · see citing works
“from B cells which prevents the release of IL-6 from DCs [57].”
BackgroundIrla, M., Küpfer, N., Suter, T. B., Lissilaa, R., Benkhoucha, M., Skupsky, J., Lalive, P. H., Fontana, A., Reith, W., & Hugues, S. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092627 · Cited by 139 · see citing works
“In accordance with previous studies (Fillatreau et al., 2002; Lampropoulou et al., 2008; by promoting the selective expansion of natural T reg cells.”
ResultInfluentialRegulation of B‐cell responses by Toll‐like receptors
Browne, E. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03587.x · Cited by 150 · see citing works
Sayi, A., Kohler, E., Toller, I., Flavell, R., Müller, W., Roers, A., & Müller, A. (2011) · Journal of Immunology · doi:10.4049/jimmunol.1002269 · Cited by 146 · see citing works
“All B cells can, in principle, produce IL-10 upon TLR-2, -4, or -9 stimulation or T cell-dependent activation (14, 15), with particularly strong production being attributed to CD5 peritoneal B-1a cells (16), intestinal CD19CD1d cells (9), and splenic CD1dCD5 “B10” cells (8).”
BackgroundUnique B Cell Differentiation Profile in Tolerant Kidney Transplant Patients
Chesneau, M., Pallier, A., Braza, F., Lacombe, G., Gallou, S. L., Baron, D., Giral, M., Danger, R., Guerif, P., Aubert-Wastiaux, H., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12508 · Cited by 144 · see citing works
Ochoa-Repáraz, J., Mielcarz, D., Haque-Begum, S., & Kasper, L. (2010) · Gut microbes · doi:10.4161/gmic.1.2.11515 · Cited by 142 · see citing works
Regulatory functions of innate-like B cells
Zhang, X. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.63 · Cited by 140 · see citing works
Regulation of immunity and autoimmunity by B cells.
Mauri, C. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.009 · Cited by 137 · see citing works
“These mice develop exacerbated EAE compared to wild-type mice [37].”
BackgroundRegulation of Interleukin-10 Expression
Rutz, S., & Ouyang, W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_5 · Cited by 166 · see citing works
Pillai, S., Mattoo, H., & Cariappa, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.10.007 · Cited by 132 · see citing works
“Since lupus pathogenesis is driven by chromatin derived autoantigens that can both engage the BCR and activate endosomal TLRs, auto-antigen specific B cell differentiation into long-lived plasma cells may occur more readily in this disease than in many other auto-immune disorders.”
BackgroundInfluentialToll‐like Receptors in Autoimmunity
Fischer, M., & Ehlers, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.012 · Cited by 132 · see citing works
The Dynamics of B Cell Aging in Health and Disease
de Mol, J., Kuiper, J., Tsiantoulas, D., & Foks, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733566 · Cited by 155 · see citing works
“In the adaptive pathway, BREGS present antigens to CD4 T cells and become activated through CD40-CD40L and IL-21 signals (77), whereas in the innate pathway, TLR2 and TLR9 signaling and IL-1b play important roles (78).”
BackgroundMatsushita, T., Kobayashi, T., Mizumaki, K., Kano, M., Sawada, T., Tennichi, M., Okamura, A., Hamaguchi, Y., Iwakura, Y., Hasegawa, M., et al. (2018) · Science Advances · doi:10.1126/sciadv.aas9944 · Cited by 131 · see citing works
“The CD40-CD40L interaction and antigen-specific signals were reported to be essential for IL-10 production from B cells (3), while TLR signals strongly augment the production of IL-10 in mice (23) and humans (24).”
BackgroundLampropoulou, V., Calderon‐Gomez, E., Roch, T., Neves, P., Shen, P., Stervbo, U., Boudinot, P., Anderton, S. M., & Fillatreau, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00855.x · Cited by 130 · see citing works
“Naive B cells must first receive a specific signal before they can produce IL10 upon BCR ⁄CD40 stimulation.”
BackgroundInfluentialSelf-citationAutocrine IL‐10 promotes human B‐cell differentiation into IgM‐ or IgG‐secreting plasmablasts
Heine, G., Drozdenko, G., Grün, J. R., Chang, H.-D., Radbruch, A., & Worm, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201343822 · Cited by 127 · see citing works
TLR‐mediated STAT3 and ERK activation controls IL‐10 secretion by human B cells
Liu, B.-S., Cao, Y., Huizinga, T., Hafler, D., & Toes, R. (2014) · European Journal of Immunology · doi:10.1002/eji.201344341 · Cited by 123 · see citing works
Regulatory B cells in ANCA-associated vasculitis
Wilde, B., Thewissen, M., Damoiseaux, J., Knippenberg, S., Hilhorst, M., van Paassen, P., Witzke, O., & Tervaert, J. C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202986 · Cited by 122 · see citing works
NFATc1 affects mouse splenic B cell function by controlling the calcineurin–NFAT signaling network
Bhattacharyya, S., Deb, J., Patra, A., Pham, D. A. T., Chen, W., Vaeth, M., Berberich-Siebelt, F., Klein-Hessling, S., Lamperti, E., Reifenberg, K., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100945 · Cited by 122 · see citing works
“This suppressive effect of NFATc1/ B cells was markedly reduced by adding the IL-10–specific antibody JES5-2A5, which relieved IL-10–mediated inhibition of cytokine production of T cells by B cells (Lampropoulou et al., 2008).”
BackgroundMethodInfluentialDang, V. D., Hilgenberg, E., Ries, S., Shen, P., & Fillatreau, S. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.02.009 · Cited by 125 · see citing works
Self-citationEffector and regulatory B cells in immune-mediated kidney disease
Oļeiņika, K., Mauri, C., & Salama, A. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0074-7 · Cited by 115 · see citing works
Killer B lymphocytes: the evidence and the potential
Lundy, S. K. (2009) · Inflammation Research · doi:10.1007/s00011-009-0014-x · Cited by 113 · see citing works
Duggal, N. A., Upton, J., Phillips, A. C., Sapey, E., & Lord, J. (2013) · Aging Cell · doi:10.1111/acel.12114 · Cited by 110 · see citing works
“Expression of TLR1, TLR2, TLR4, TLR7 and TLR9 transcripts has been reported on B cells (Barr et al., 2007), and TLR-activated B cells are capable of resolving autoimmune disorders by inhibiting pathogenic T cells via IL10 production (Lampropoulou et al., 2008).”
BackgroundCytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis
Li, R., Rezk, A., Healy, L. M., Muirhead, G., Prat, A., Gommerman, J. L., & Bar‐Or, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00626 · Cited by 100 · see citing works
“For example, innate signal-induced IL-10-producing B cells are able to down-regulate pathogenic T-cell responses indirectly through dendritic cells (14), whereas adaptive signal-induced IL-10-producing B cells directly down-regulate antigen-specific T-cell responses (15, 16).”
BackgroundTranscriptomics identify CD9 as a marker of murine IL10-competent regulatory B cells
Sun, J.-B., Wang, J.-G., Pefanis, E., Chao, J. L., Rothschild, G., Tachibana, I., Chen, J.-K., Ivanov, I., Rabadán, R., Takeda, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.070 · Cited by 107 · see citing works
“Bregs are found enriched in phenotypically diverse B-cell subsets.”
BackgroundInfluentialB cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis
Kala, M., Rhodes, S. N., Piao, W.-H., Shi, F., Campagnolo, D. I., & Vollmer, T. L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.015 · Cited by 103 · see citing works
Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation
Peng, B., Ming, Y., & Yang, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0152-y · Cited by 103 · see citing works
Correale, J. D., & Farez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900897 · Cited by 100 · see citing works
“TLR9 contributes to EAE severity (52) but has no influence on B cell-driven disease resolution (51).”
BackgroundInfluentialCellular targets of regulatory B cell-mediated suppression.
Rosser, E., Blair, P., & Mauri, C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.01.014 · Cited by 101 · see citing works
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
Nelson, M. A., Ngamcherdtrakul, W., Luoh, S.-W., & Yantasee, W. (2021) · Cancer Metastasis Review · doi:10.1007/s10555-021-09968-0 · Cited by 99 · see citing works
Miyagaki, T., Fujimoto, M., & Sato, S. (2015) · International Immunology · doi:10.1093/intimm/dxv026 · Cited by 99 · see citing works
Huu, D. L., Matsushita, T., Jin, G., Hamaguchi, Y., Hasegawa, M., Takehara, K., Tedder, T., & Fujimoto, M. (2013) · Blood · doi:10.1182/blood-2012-11-465658 · Cited by 97 · see citing works
The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease
Soldevila, G., Raman, C., & Lozano, F. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.003 · Cited by 97 · see citing works
“IL-10 producing B-cells have an important role in controlling mouse models of autoimmune diseases, such as EAE [34], collagen-induced arthritis (CIA) [35], inflammatory bowel disease (IBD) [36], contact hypersensivity (CHS) [33 ] and SLE [37].”
MethodInfluentialHaeberlein, S., Obieglo, K., Ozir-Fazalalikhan, A., Chayé, M. A. M., Veninga, H., van der Vlugt, L. E. P. M., Voskamp, A., Boon, L., den Haan, J. M. M., Westerhof, L. B., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006539 · Cited by 96 · see citing works
Zhang, W., Zhang, H., Liu, S., Xia, F., Kang, Z., Zhang, Y., Liu, Y., Xiao, H. Q., Chen, L., Huang, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901340116 · Cited by 103 · see citing works
Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells
Kubo, M., & Motomura, Y. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00275 · Cited by 99 · see citing works
B cell immunosenescence: different features of naive and memory B cells in elderly
Buffa, S., Bulati, M., Pellicanò, M., Dunn‐Walters, D. K., Wu, Y.-C. B., Candore, G., Vitello, S., Caruso, C., & Colonna‐Romano, G. (2011) · Biogerontology · doi:10.1007/s10522-011-9353-4 · Cited by 104 · see citing works
“It has been demonstrated (Lampropoulou et al. 2008) that TLR2, TLR4 and TLR9 engagement induces IL-10”
Pathogen manipulation of B cells: the best defence is a good offence
Nothelfer, K., Sansonetti, P., & Phalipon, A. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3415 · Cited by 94 · see citing works
Anolik, J., Looney, R. J., Lund, F., Randall, T., & Sanz, I. (2009) · Immunologic research · doi:10.1007/s12026-009-8096-7 · Cited by 92 · see citing works
“B cells may also directly suppress Th1 and Th17-mediated diseases (37).”
BackgroundRay, A., Mann, M. K., Basu, S., & Dittel, B. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.037 · Cited by 88 · see citing works
“Furthermore, signaling through either TLR4 (LPS) or TLR9 (CpG) induced the expression of IL-10 in B cells, but only TLR2/4 expression by B cells regulated recovery from EAE (Lampropoulou et al., 2008).”
InfluentialTh17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 91 · see citing works
Ngoi, S. M., Tovey, M. G., & Vella, A. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7670 · Cited by 78 · see citing works
“Similarly, TLR ligand-activated B cells antagonized IFN- production by CD4 T cells through an IL-10-dependent mechanism (53).”
BackgroundRegulatory B cells: Phenotype, function and role in transplantation.
Wortel, C., & Heidt, S. (2017) · Transplant Immunology · doi:10.1016/j.trim.2017.02.004 · Cited by 85
Regulatory functions of B cells in allergic diseases
Braza, F., Chesne, J., Castagnet, S., Magnan, A., & Brouard, S. (2014) · Allergy. European Journal of Allergy and Clinical Immunology · doi:10.1111/all.12490 · Cited by 83 · see citing works
Miranda-Hernandez, S., Gerlach, N., Fletcher, J., Biros, E., Mack, M., Körner, H., & Baxter, A. (2011) · Journal of Immunology · doi:10.4049/jimmunol.1001992 · Cited by 83 · see citing works
“The dependence of EAE induction on MyD88 signaling has been reported previously (32, 33, 67), as has the lack of an EAE phenotype in TLR6-deficient mice (33); the role of TLR1 in EAE has”
BackgroundCommensal gut flora and brain autoimmunity: a love or hate affair?
Berer, K., & Krishnamoorthy, G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0949-9 · Cited by 82 · see citing works
Regulation of autoimmune encephalomyelitis by toll-like receptors.
Marta, M., Meier, U., & Lobell, A. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.01.006 · Cited by 81 · see citing works
“In another study, clinical signs of MOG35–55-induced EAE in mice with TLR9−/− B cells were similar to mice with TLR9 B cells [24].”
BackgroundResultB cells and Immunological Tolerance
Orduño, N. M., Quach, T., & Sanz, I. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.240 · Cited by 81 · see citing works
“Inhibition of Th1 and Th17 cells (TLR-mediated) (101)”
BackgroundInfluentialImmunological Perspective: Helicobacter pylori Infection and Gastritis
Yang, H., & Hu, B. (2022) · Mediators of Inflammation · doi:10.1155/2022/2944156 · Cited by 85 · see citing works
“TLR signaling in B cells inhibits inflammatory T cell response (both Th1 and Th17 cells), which can be controlled by TLR agonists [57].”
BackgroundB Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis
Bénard, A., Sakwa, I., Schierloh, P., Colom, A., Mercier, I., Tailleux, L., Jouneau, L., Boudinot, P., Saati, T. A., Lang, R., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1475oc · Cited by 88 · see citing works
“Because MyD88 signaling controls the production of IL-6 and IL-10 by B cells (49), we cannot exclude that these cytokines play a part in the observed phenotype.”
BackgroundSelf-citationA regulatory CD9+ B‐cell subset inhibits HDM‐induced allergic airway inflammation
Braza, F., Chesné, J., Durand, M., Dirou, S., Brosseau, C., Mahay, G., Cheminant, M., Magnan, A., & Brouard, S. (2015) · Allergy. European Journal of Allergy and Clinical Immunology · doi:10.1111/all.12697 · Cited by 79 · see citing works
“Moreover, IL-10-secreting B cells can inhibit the production of IL-6 and IL-23 by dendritic cells in vitro, which might explain how Bregs can reduce TH17 responses in vivo (42).”
BackgroundLiu, X., Jiang, X., Liu, R.-H., Wang, L., Qian, T., Zheng, Y.-J., Deng, Y.-T., Huang, E., Xu, F.-K., Wang, J.-Y., et al. (2015) · Hepatology · doi:10.1002/hep.28001 · Cited by 78 · see citing works
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm
Batoulis, H., Addicks, K., & Küerten, S. (2010) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2010.06.006 · Cited by 71 · see citing works
Jin, G., Hamaguchi, Y., Matsushita, T., Hasegawa, M., Huu, D. L., Ishiura, N., Naka, K., Hirao, A., Takehara, K., & Fujimoto, M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.044 · Cited by 77 · see citing works
“Nonetheless, activation through BCR and CD40 is also needed for the induction of IL-10–producing regulatory B cells to optimally suppress autoimmunity.(2,13,14,31) Thus, a 2-step activation model has been proposed.”
BackgroundMethodKruglov, A., Lampropoulou, V., Fillatreau, S., & Nedospasov, S. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100663 · Cited by 75 · see citing works
“Mice were scored daily, as described elsewhere (18).”
MethodSelf-citation
- Authors
- Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Gómez, E. C., Sweenie, C. H., Hao, Y., Freitas, A. A., Steinhoff, U., Anderton, S. M., & Fillatreau, S.
- Affiliations
- German Rheumatism Research Centre (DE)
- Deutsches Rheuma-ForschungsZentrum , Berlin ,
- University of Edinburgh (GB)
- Centre National de la Recherche Scientifique (FR)
- Unité de Recherche Associée Centre National de la Recherche Scientifique 1961, Institut Pasteur , Paris ,
- Max Planck Institute for Infection Biology (DE)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-01
- Volume
- 180
- Issue
- 7
- Pages
- 4763-4773
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1918941126
- Cited by
- 436
- References
- 81
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 11 · 2023: 13 · 2022: 17 · 2021: 23 · 2020: 13 · 2019: 17 · 2018: 24 · 2017: 24 · 2016: 41 · 2015: 31 · 2014: 34 · 2013: 40 · 2012: 33
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- MyD88, T cell-mediated autoimmunity, experimental autoimmune encephalomyelitis, Th17 cells, Th1 cells, B cell suppression, TLR agonists, dendritic cells, macrophages
- MeSH terms
- Animals, B-Lymphocytes, Dendritic Cells, Encephalomyelitis, Autoimmune, Experimental, Lymphocyte Activation, Mice, Inbred C57BL, Mycobacterium tuberculosis, T-Lymphocytes, Signal Transduction, Autoimmunity, Interleukin-10, Mice, Knockout, Toll-Like Receptors, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review